| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.62▲ | 8.65▲ | 8.70▼ | 8.76▼ | 8.45▲ |
| MA10 | 8.64▲ | 8.69▼ | 8.71▼ | 8.68▲ | 8.48▲ |
| MA20 | 8.65▲ | 8.71▼ | 8.80▼ | 8.39▲ | 8.43▲ |
| MA50 | 8.69▼ | 8.79▼ | 8.73▼ | 8.50▲ | 7.59▲ |
| MA100 | 8.74▼ | 8.68▼ | 8.54▲ | 8.33▲ | 7.31▲ |
| MA200 | 8.74▼ | 8.37▲ | 8.25▲ | 7.39▲ | 8.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.008▼ | -0.025▼ | 0.048▲ | -0.008▼ |
| RSI | 52.233▲ | 45.909▼ | 45.866▼ | 54.194▲ | 56.421▲ |
| STOCH | 25.891 | 49.690 | 36.599 | 62.341 | 39.894 |
| WILL %R | -25.806 | -37.209 | -64.935 | -46.898 | -44.280 |
| CCI | 74.597 | -42.295 | -109.283▼ | 16.392 | 50.323 |
| MA | $NVCT Price Crossed Below MA(7) | Set Alert |
|
Tuesday, March 31, 2026 01:00 AM
Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative ...
|
|
Monday, March 30, 2026 05:01 PM
Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/04/26 | 8.545 | 8.72 | 8.545 | 8.68 | 12,478 |
| 28/04/26 | 8.80 | 8.80 | 8.63 | 8.69 | 45,044 |
| 27/04/26 | 8.83 | 9.0899 | 8.74 | 8.75 | 34,756 |
| 24/04/26 | 8.76 | 9.2099 | 8.52 | 8.90 | 72,057 |
| 23/04/26 | 8.88 | 8.88 | 8.35 | 8.79 | 34,813 |
| 22/04/26 | 8.61 | 8.96 | 8.61 | 8.82 | 50,271 |
| 21/04/26 | 8.39 | 8.7699 | 8.25 | 8.58 | 66,565 |
| 20/04/26 | 8.6822 | 8.88 | 8.26 | 8.33 | 31,667 |
| 17/04/26 | 8.53 | 8.92 | 8.33 | 8.90 | 92,572 |
| 16/04/26 | 8.44 | 8.44 | 8.29 | 8.35 | 19,857 |
|
|
||||
|
|
||||
|
|